Karuna Therapeutics Buy Hold or Sell Recommendation

KRTXDelisted Stock  USD 329.83  0.00  0.00%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Karuna Therapeutics is 'Not Rated'. Macroaxis provides Karuna Therapeutics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding KRTX positions. The advice algorithm takes into account all of Karuna Therapeutics' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Karuna Therapeutics' buy or sell advice are summarized below:
Real Value
255.12
Hype Value
329.52
Market Value
329.83
Naive Value
350.74
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Karuna Therapeutics given historical horizon and risk tolerance towards Karuna Therapeutics. When Macroaxis issues a 'buy' or 'sell' recommendation for Karuna Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
In addition, we conduct extensive research on individual companies such as Karuna and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Karuna Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

Execute Karuna Therapeutics Buy or Sell Advice

The Karuna recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Karuna Therapeutics. Macroaxis does not own or have any residual interests in Karuna Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Karuna Therapeutics' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Karuna TherapeuticsBuy Karuna Therapeutics
Not Rated
For the selected time horizon Karuna Therapeutics has a Risk Adjusted Performance of 0.0834, Jensen Alpha of 0.8362, Total Risk Alpha of (0.54), Sortino Ratio of 0.7815 and Treynor Ratio of (1.80)
Macroaxis provides trade recommendations on Karuna Therapeutics to complement and cross-verify current analyst consensus on Karuna Therapeutics. Our advice engine determines the firm's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure Karuna Therapeutics is not overpriced, please verify all Karuna Therapeutics fundamentals, including its current ratio, and the relationship between the ebitda and target price . Given that Karuna Therapeutics has a price to earning of (19.88) X, we recommend you to check Karuna Therapeutics market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your last-minute risk tolerance and investing horizon.

Karuna Therapeutics Trading Alerts and Improvement Suggestions

Karuna Therapeutics is not yet fully synchronised with the market data
Karuna Therapeutics has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 654 K. Net Loss for the year was (433.68 M) with profit before overhead, payroll, taxes, and interest of 10.64 M.
Karuna Therapeutics currently holds about 407.41 M in cash with (385.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 13.6.
Over 86.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: Disposition of 17350 shares by Stephen Brannan of Karuna Therapeutics at 187.26 subject to Rule 16b-3

Karuna Therapeutics Returns Distribution Density

The distribution of Karuna Therapeutics' historical returns is an attempt to chart the uncertainty of Karuna Therapeutics' future price movements. The chart of the probability distribution of Karuna Therapeutics daily returns describes the distribution of returns around its average expected value. We use Karuna Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Karuna Therapeutics returns is essential to provide solid investment advice for Karuna Therapeutics.
Mean Return
0.79
Value At Risk
-0.56
Potential Upside
1.80
Standard Deviation
5.91
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Karuna Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Disposition of 8500 shares by Jonas Jeffrey M of Karuna Therapeutics at 128.01 subject to Rule 16b-3 [view details]

Karuna Therapeutics Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Karuna . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Karuna Therapeutics Buy or Sell Advice

When is the right time to buy or sell Karuna Therapeutics? Buying financial instruments such as Karuna Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Karuna Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Apparel Thematic Idea Now

Apparel
Apparel Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Apparel theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Apparel Theme or any other thematic opportunities.
View All  Next Launch
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Consideration for investing in Karuna Stock

If you are still planning to invest in Karuna Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Karuna Therapeutics' history and understand the potential risks before investing.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies